981 Management of Epistaxis During The COVID-19 Pandemic Our Experience
Author(s) -
Meg Eastwood,
Chris Metcalfe,
A Lovett,
M. Isles
Publication year - 2021
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1093/bjs/znab134.105
Subject(s) - medicine , pandemic , audit , covid-19 , medical emergency , airway management , emergency medicine , airway , surgery , disease , management , infectious disease (medical specialty) , economics
Epistaxis is a frequently encountered emergency by ENT services. With the COVID-19 outbreak, examination and procedures on the upper airway may put otolaryngologists at increased risk of infection. ENT UK released new guidance for the management of epistaxis during COVID-19 pandemic to safely manage epistaxis and reduce admissions. We report our experience in managing epistaxis using a locally approved protocol using this guidance. Method Prospective audit of management and outcomes of patients presenting to acute ENT services at a large teaching hospital with epistaxis over a 3-month period. Results 58 patients attended with epistaxis. Various management strategies were used with 50% managed with non-absorbable packing. 15 cases required admission only 8 solely due to epistaxis. Only 5 cases (8.6%) reported re-bleeding within 30 days with one case (1.7%) requiring readmission. Conclusions The current guidance appears to be a safe and effective method for managing epistaxis and minimising the number of admissions which may lead to a permanent shift in epistaxis management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom